Form 4: Varex Imaging CHRO Reports RSU Vesting & New Grant

Varex Imaging's Chief Human Resources Officer, Karen L. Aranki, reported the vesting of 6,665 restricted stock units and the grant of 21,875 new units.

Summary

• Karen L. Aranki, Chief Human Resources Officer of Varex Imaging Corp (VREX), reported transactions on December 10, 2025.
• 6,665 shares of common stock were acquired upon the vesting of Restricted Stock Units (RSUs).
• 1,923 shares of common stock were disposed of at a price of $11.7 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Aranki beneficially owns 4,919 shares of common stock directly.
• 6,665 Restricted Stock Units, originally granted on December 10, 2023, vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027.
• An additional 21,875 Restricted Stock Units were granted on December 10, 2025, scheduled to vest 50% on December 10, 2027, and 50% on December 10, 2029.
• After these derivative transactions, Aranki beneficially owns 6,666 unvested RSUs from the 2023 grant and 21,875 unvested RSUs from the 2025 grant.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation (RSU vesting and new grants) and tax withholding, which are neutral events in terms of company performance or outlook.

Positives

• The grant of 21,875 new Restricted Stock Units indicates continued incentive and alignment of management interests with shareholder value.
• The vesting of 6,665 Restricted Stock Units represents a successful realization of previously granted equity compensation.

Negatives

• The disposition of 1,923 shares for tax withholding, while a common practice, reduces the direct common stock ownership of the reporting person.

Future Outlook

The reporting person has future equity compensation scheduled to vest, with 50% of the 2025 RSU grant and the remaining 50% of the 2023 RSU grant scheduled to vest on December 10, 2027, and the final 50% of the 2025 RSU grant scheduled to vest on December 10, 2029.

Industry Context

This filing reflects a routine executive compensation event, where Restricted Stock Units (RSUs) vest and new grants are issued, a common practice across various industries to incentivize and retain key personnel. The sale of shares to cover tax obligations upon vesting is also a standard procedure.

Comparison to Industry Standards

• The structure of RSU grants with multi-year vesting schedules is a standard practice in executive compensation across publicly traded companies, aligning executive interests with long-term company performance.
• The disposition of shares to cover tax withholding obligations upon RSU vesting is a common and expected event, consistent with practices observed in comparable companies' executive compensation programs.

Stakeholder Impact

• Shareholders: Minor impact on the outstanding share count due to the vesting and subsequent sale for tax purposes. The new RSU grant aligns executive incentives with long-term shareholder value.
• Employees: Reflects standard executive compensation practices, potentially influencing broader compensation strategies within the company.

Next Steps

• Delivery of vested shares to the reporting person upon future vesting dates (December 10, 2027, and December 10, 2029).

Key Dates

Keywords

Varex Imaging, VREX, Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Vesting, Executive Compensation, Equity Grant